CRMD
Price
$7.69
Change
+$0.34 (+4.63%)
Updated
Feb 6 closing price
Capitalization
605.89M
50 days until earnings call
Intraday BUY SELL Signals
MURA
Price
$2.08
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
Capitalization
35.38M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRMD vs MURA

Header iconCRMD vs MURA Comparison
Open Charts CRMD vs MURABanner chart's image
CorMedix
Price$7.69
Change+$0.34 (+4.63%)
Volume$1.57M
Capitalization605.89M
Mural Oncology
Price$2.08
Change-$0.00 (-0.00%)
Volume$46.25K
Capitalization35.38M
CRMD vs MURA Comparison Chart in %
CRMD
Daily Signal:
Gain/Loss:
MURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRMD vs. MURA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and MURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (CRMD: $7.69 vs. MURA: $2.04)
Brand notoriety: CRMD and MURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 47% vs. MURA: 92%
Market capitalization -- CRMD: $604.71M vs. MURA: $35.38M
CRMD [@Biotechnology] is valued at $604.71M. MURA’s [@Biotechnology] market capitalization is $35.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 1 FA rating(s) are green whileMURA’s FA Score has 0 green FA rating(s).

  • CRMD’s FA Score: 1 green, 4 red.
  • MURA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRMD is a better buy in the long-term than MURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 5 TA indicator(s) are bullish while MURA’s TA Score has 1 bullish TA indicator(s).

  • CRMD’s TA Score: 5 bullish, 5 bearish.
  • MURA’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, MURA is a better buy in the short-term than CRMD.

Price Growth

CRMD (@Biotechnology) experienced а -0.90% price change this week, while MURA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

CRMD is expected to report earnings on Mar 31, 2026.

MURA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($606M) has a higher market cap than MURA($35.4M). MURA YTD gains are higher at: 0.000 vs. CRMD (-33.878). CRMD has higher annual earnings (EBITDA): 112M vs. MURA (-131.93M). MURA has more cash in the bank: 77.1M vs. CRMD (55.7M). MURA has less debt than CRMD: MURA (5.17M) vs CRMD (149M). CRMD has higher revenues than MURA: CRMD (214M) vs MURA (0).
CRMDMURACRMD / MURA
Capitalization606M35.4M1,712%
EBITDA112M-131.93M-85%
Gain YTD-33.8780.000-
P/E Ratio3.47N/A-
Revenue214M0-
Total Cash55.7M77.1M72%
Total Debt149M5.17M2,880%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDMURA
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signal:
Gain/Loss:
MURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KGDZX36.640.91
+2.55%
DWS Global Small Cap R6
ACFSX75.361.48
+2.00%
American Century Focused Dynamic Gr I
SHSAX65.431.15
+1.79%
BlackRock Health Sciences Opps Inv A
FIQPX73.571.19
+1.64%
Fidelity Advisor Emerging Asia Z
NEQCX12.850.01
+0.08%
Neuberger U.S. Equity Impact C

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with HOTH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then HOTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
+4.63%
HOTH - CRMD
40%
Loosely correlated
+4.95%
MURA - CRMD
38%
Loosely correlated
N/A
CNSP - CRMD
37%
Loosely correlated
-0.88%
HOWL - CRMD
37%
Loosely correlated
+1.02%
BCAB - CRMD
36%
Loosely correlated
+10.78%
More

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with MIST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
N/A
MIST - MURA
55%
Loosely correlated
+2.33%
CRMD - MURA
36%
Loosely correlated
+4.63%
SAVA - MURA
34%
Loosely correlated
+7.41%
DTIL - MURA
34%
Loosely correlated
+6.44%
IPSC - MURA
33%
Poorly correlated
+1.80%
More